Chemopreventive efficacy of salvianolic acid B phospholipid complex loaded nanoparticles against experimental oral carcinogenesis: implication of sustained drug release.

Ann Transl Med · 2022 · PMC8987877 · PMID 35402586

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

a decreasing trendP=0.059so close (0.05 < p ≤ 0.1)

The incidence of moderate dysplasia or worse in groups A-C showed a decreasing trend (P=0.059, one-way ANOVA) from the 4NQO-exposed group (64.0%) to the free-SAB-treated (45.5%) and nano-SAB-treated (36.3%) groups.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.